Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction.

Abstract	Chest infections with organisms resistant to conventional antibiotics are common in patients with chronic lung disease. We have studied the use of imipenem in 40 (28 M 12 F) patients admitted for treatment of chest infections. Patients were treated with imipenem 0.5 g four times daily by intravenous infusion for 6.3 +/- 1.6 (S.D.) days. Forty-six respiratory pathogens were cultured from 36 patients including 18 Haemophilus influenzae, 6 H. parainfluenzae, 6 Streptococcus pneumoniae, 8 Pseudomonas aeruginosa, and 6 Branhamella catarrhalis. Forty-three of the 46 isolates were sensitive to imipenem, 28 to ampicillin, 33 to tetracycline and 35 to cotrimoxazole. Thirty-eight of the 40 patients improved clinically, and 34 of the 36 patients with positive sputum culture had no pathogens in their sputum after treatment. Twenty patients developed minor phlebitis at the infusion site but there were few other side effects. Imipenem may prove useful in the treatment of chest infections, particularly when the organism is resistant to conventional antibiotics.
Authors	C G Wathen, N J Carbarns, P A Jones, A Millar, M J Croughan, M A Calder, N J Douglas
Journal	The Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 21 Issue 1 Pg. 107-12 (Jan 1988) ISSN: 0305-7453 [Print] England
PMID	3356618 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Anti-Bacterial Agents Cyclopropanes Drug Combinations Thienamycins Cilastatin Imipenem Cilastatin, Imipenem Drug Combination
Topics	Adult Aged Aged, 80 and over Anti-Bacterial Agents (administration & dosage, adverse effects, therapeutic use) Cilastatin Cilastatin, Imipenem Drug Combination Cyclopropanes (administration & dosage, adverse effects, therapeutic use) Drug Combinations (administration & dosage, adverse effects, therapeutic use) Female Humans Imipenem Infusions, Intravenous Lung Diseases, Obstructive (complications) Male Middle Aged Respiratory Tract Infections (drug therapy, etiology, microbiology) Thienamycins (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!